Literature DB >> 17848496

The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?

Jocelyn Gravel1, Lucie Opatrny, Stan Shapiro.   

Abstract

BACKGROUND: Intention-to-treat (ITT) is an approach to the analysis of randomized controlled trials (RCT) in which patients are analyzed as randomized regardless of the treatment actually received.
PURPOSE: To ascertain the proportion of RCT reporting the use of intention-to-treat and the accuracy of that report and to examine the distribution and analysis of missing data for the studies reporting an ITT analysis.
METHOD: We conducted a cross-sectional literature review of RCTs reported in 10 medical journals in 2002. All articles were assessed using a standardized form. Two evaluators independently reviewed a 10% sample of articles to assess reliability. Subsequently, one evaluator reviewed the remaining articles. The proportion of articles reporting the use of ITT was calculated. Among these, the proportion of articles that ;analyzed patients as randomized' and the proportion and analysis of missing data were evaluated using standardized definitions.
RESULTS: Of the 403 articles, 249 (62%) reported the use of ITT. Among these, available patients were clearly analyzed as randomized in 192 (77%). Authors used a modified ITT in 23 (9%); clearly violated a major component of ITT in 17 (7%), and the approach used was unclear in 17 (7%). More than 60% of articles had missing data in their primary analysis. Few articles reported a strategy for missing data. The main reason for missing data was loss to follow-up. LIMITATIONS: A single evaluator evaluated most articles, but the high concordance obtained during the inter-rater evaluation suggests that the assessments were consistent. In addition, the small spectrum of journals limits generalizability. Finally, there could be a difference between what was reported and what was performed.
CONCLUSIONS: This study emphasizes that authors use the label ;intention-to-treat' quite differently. The most common use refers to the analysis of all available subjects as randomized regardless of the missing data aspect.

Entities:  

Mesh:

Year:  2007        PMID: 17848496     DOI: 10.1177/1740774507081223

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  35 in total

1.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

2.  Intention-to-treat analyses in behavioral medicine randomized clinical trials.

Authors:  Sherry L Pagoto; Andrea T Kozak; Priya John; Jamie S Bodenlos; Donald Hedeker; Bonnie Spring; Kristin L Schneider
Journal:  Int J Behav Med       Date:  2009

3.  Modified intention to treat reporting in randomised controlled trials: systematic review.

Authors:  Iosief Abraha; Alessandro Montedori
Journal:  BMJ       Date:  2010-06-14

4.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

Authors:  Sally Hopewell; Susan Dutton; Ly-Mee Yu; An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

5.  Analyzing Longitudinal Data with Multilevel Models: An Example with Individuals Living with Lower Extremity Intra-articular Fractures.

Authors:  Oi-Man Kwok; Andrea T Underhill; Jack W Berry; Wen Luo; Timothy R Elliott; Myeongsun Yoon
Journal:  Rehabil Psychol       Date:  2008-08

6.  Associations of housing mobility interventions for children in high-poverty neighborhoods with subsequent mental disorders during adolescence.

Authors:  Ronald C Kessler; Greg J Duncan; Lisa A Gennetian; Lawrence F Katz; Jeffrey R Kling; Nancy A Sampson; Lisa Sanbonmatsu; Alan M Zaslavsky; Jens Ludwig
Journal:  JAMA       Date:  2014-03-05       Impact factor: 56.272

Review 7.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

Authors:  Eveline Nüesch; Sven Trelle; Stephan Reichenbach; Anne W S Rutjes; Elizabeth Bürgi; Martin Scherer; Douglas G Altman; Peter Jüni
Journal:  BMJ       Date:  2009-09-07

8.  LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact.

Authors:  Elie A Akl; Matthias Briel; John J You; Francois Lamontagne; Azim Gangji; Tali Cukierman-Yaffe; Mohamad Alshurafa; Xin Sun; Kara A Nerenberg; Bradley C Johnston; Claudio Vera; Edward J Mills; Dirk Bassler; Arturo Salazar; Neera Bhatnagar; Jason W Busse; Zara Khalid; Sd Walter; Deborah J Cook; Holger J Schünemann; Douglas G Altman; Gordon H Guyatt
Journal:  Trials       Date:  2009-06-11       Impact factor: 2.279

9.  Missing outcomes in randomized trials: addressing the dilemma.

Authors:  Douglas G Altman
Journal:  Open Med       Date:  2009-05-12

10.  Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Authors:  Nicolas Rasmussen; Kirby Lee; Lisa Bero
Journal:  Trials       Date:  2009-12-16       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.